Method for detecting the change in an analyte due to hemolysis in a fluid sample

• US 5,416,026 A
• Filed: 10/04/1993
• Issued: 05/16/1995
• Est. Priority Date: 10/04/1993
• Status: Expired due to Term

• Current Assignee: Abbott Point Of Care Incorporated (Abbott Laboratories)
• Original Assignee: i STAT Corporation (Abbott Laboratories)
• Inventors: Davis, Graham
• Primary Examiner(s): Housel, James C.
• Assistant Examiner(s): Soderquist, Arlen
• Application Number:
  US08/131,527
• Time in Patent Office: 589 Days
• Field of Search: 436/66, 436/79, 436/169, 436/175, 436/177, 436/73
• US Class Current: 436/66
• CPC Class Codes: G01N 33/725 using peroxidative activity
• CPC Class Codes: G01N 33/726 Devices
• CPC Class Codes: Y10T 436/25125 Digestion or removing interfering materials
• CPC Class Codes: Y10T 436/25375 Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]

Abstract

The present invention concerns a method of detecting hemolysis in a whole-blood sample, a method of determining an elevation in the potassium ion concentration of a whole-blood sample, an apparatus for detecting hemolysis and/or determining an elevation in the potassium ion concentration in a fluid sample, an apparatus for detecting hemolysis and/or determining an elevation in the potassium ion concentration in a whole-blood sample, and a single-use cartridge containing a plurality of microfabricated biosensors which further contains a hemolysis detection unit.

Claims

1. A method of estimating a change in an analyte in a whole-blood sample which is due to the hemolysis of red blood cells, comprising:

(a) contacting a whole-blood sample comprising intact red blood cells with a dry separation material having a site where said whole blood sample is introduced and a remainder, said material having physical characteristics effective to separate by wicking action a fraction, which contains extracellular hemoglobin that may be present in said sample, from the intact red blood cells;

(b) allowing said sample to remain in contact with said material for a period of time sufficient to effect said separation;

(c) detecting at a location in said remainder the presence of extracellular hemoglobin in said fraction; and

(d) estimating the change in said analyte in said sample which is due to the hemolysis of red blood cells.

2. The method of claim 1 in which said fraction includes plasma.

3. The method of claim 2 in which said fraction is separated from said intact red blood cells by a wicking action of said dry separation material, wherein said red blood cells are retarded relative to the separated fraction.

4. The method of claim 1 in which said detecting step comprises visually inspecting said fraction for the presence of a color hue.

5. The method of claim 4 which further comprises comparing said color hue to a colored chart displaying a variety of color hues, each of said color hues indicative of an estimated concentration of extracellular hemoglobin present in a given separated fraction.

6. The method of claim 5 in which the estimated concentration of extracellular hemoglobin is at least 2 mg/dL.

7. The method of claim 5 in which the estimated concentration of extracellular hemoglobin is at least 20 mg/dL.

8. The method of claim 1 in which said detecting step comprises contacting said fraction with a chromogenic reagent.

9. The method of claim 8 in which said fraction contains hemoglobin, and said hemoglobin reacts with said chromogenic reagent to provide a visually detectable color change.

10. The method of claim 9 in which said chromogenic reagent is selected from the group consisting of o-toluidine, diisopropylbenzene dihydroperoxide and tetramethylbenzidine.

11. The method of claim 1 in which said detecting step is performed with the aid of a reflectance meter, said meter providing a reading that is a function of the concentration of extracellular hemoglobin present in said fraction.

12. The method of claim 2 or 11 which specifically detects a level of hemolysis sufficient to cause an elevation of the potassium concentration by at least 0.1 mM above the potassium concentration which would otherwise have been present in the plasma fraction had the whole-blood sample been free from hemolysis.

13. The method of claim 1, wherein said analyte is selected from the group consisting of potassium ion, lactate dehydrogenase, and acid phosphatase.

14. The method of claim 1 which further comprises adjusting the apparent concentration or activity of said analyte to account for the proportion of same which is due to the hemolysis of red blood cells.

15. The method of claim 1 in which the physical characteristics of said dry separation material include dimensions in length of from 5 to 50 mm, in width of from 1 to 10 mm, and in thickness of from 0.1 to 3.0 mm.

16. The method of claim 15, further comprising comparing said elevation of the potassium ion concentration to a pre-selected value of hemolysis, and rejecting as unreliable for clinical purposes an elevation above said pre-selected value.

17. The method of claim 1 in which said dry separation material comprises a composite medium of glass fibers, cellulose fibers and synthetic textile fibers.

18. The method of claim 1, wherein said change is an elevation.

19. The method of claim 1, wherein said change is in the concentration or activity of said analyte.

20. The method of claim 1, wherein said dry separation material does not cause visible hemolysis of said intact red blood cells.

22. The method of claim 1 or 21 which is performed in a single-use whole-blood analysis cartridge which comprises said dry separation material and an ion-selective electrode for measuring the concentration of potassium ion.

23. The method of claim 22 in which said potassium ion-selective is microfabricated on a silicon chip.

24. The method of claim 1 or 21, further comprising the step of determining the presence, concentration or activity of one or more additional physiological analytes in said whole blood sample.

25. The method of claim 24, wherein said determining comprises contacting said whole blood sample with a plurality of microfabricated biosensors.

26. The method of claim 25, wherein said additional physiological analyte is potassium.

27. The method of claim 1 or 21, wherein said dry separation material has an outermost edge and a dimensional axis defined by said site where said whole blood sample is introduced and said outermost edge, and said location in said remainder where said detecting occurs is between said outermost edge and a point one-third of the distance along said dimensional axis.

21. A method of determining the elevation in the potassium ion concentration due to hemolysis of intact red blood cells in a whole-blood sample, comprising:

(a) contacting a whole-blood sample comprising intact red blood cells with a dry separation material having a site where said whole blood sample is introduced and a remainder, said material having physical characteristics effective to separate by wicking action a plasma fraction, which contains extracellular hemoglobin that may be present in said sample, from the intact red blood cells;

(b) allowing said sample to remain in contact with said material for a period of time sufficient to effect said separation in said remainder;

(c) estimating the quantity of extracellular hemoglobin in said plasma fraction; and

(d) estimating the elevation of the potassium ion concentration in said sample which is due to hemolysis.